Formosa Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	241.79	425.79	384.71	267.34	208.92
Short-Term Investments	1,200	1,220	831.41	153.55	-
Cash & Short-Term Investments	1,442	1,646	1,216	420.89	208.92
Cash Growth	-12.39%	35.33%	188.94%	101.46%	398.99%
Other Receivables	12.56	51.66	46.44	14.72	13.88
Receivables	12.56	51.66	46.44	14.72	13.88
Inventory	4.17	2.89	-	-	-
Prepaid Expenses	57.26	26.94	25.34	20.57	11.66
Other Current Assets	0.16	0.52	0.44	0.13	0.04
Total Current Assets	1,516	1,728	1,288	456.31	234.5
Property, Plant & Equipment	43.56	29.89	34.36	10.18	8.19
Long-Term Investments	1.54	5.15	27.26	-	-
Goodwill	-	30.54	30.54	30.54	30.54
Other Intangible Assets	462.31	311.85	345.64	380.2	414.83
Other Long-Term Assets	47.89	7.05	0.65	0.67	0.65
Total Assets	2,071	2,112	1,727	877.91	688.72
Accounts Payable	0.77	-	-	-	-
Accrued Expenses	3.17	128.36	86.67	66.09	7.17
Current Portion of Leases	6.57	5.5	5.5	2.5	2.76
Current Unearned Revenue	21.29	4.51	71.33	-	-
Other Current Liabilities	134.61	59.59	94.48	0.98	9.37
Total Current Liabilities	166.42	197.95	257.98	69.57	19.3
Long-Term Leases	20.41	20.3	24.29	4.41	0.42
Long-Term Unearned Revenue	16.76	23.48	1.66	-	-
Long-Term Deferred Tax Liabilities	3.46	3.95	4.45	4.94	5.43
Other Long-Term Liabilities	407.02	318.02	297.84	331.6	270.33
Total Liabilities	614.06	563.7	586.21	410.51	295.48
Common Stock	1,510	1,510	1,341	1,136	988.32
Additional Paid-In Capital	2,279	2,279	1,780	978.52	620.49
Retained Earnings	-2,237	-2,153	-1,952	-1,630	-1,202
Comprehensive Income & Other	-95.74	-87.59	-29.91	-18.14	-14.53
Total Common Equity	1,457	1,548	1,140	466.83	392.74
Minority Interest	0.55	0.59	0.54	0.57	0.49
Shareholders' Equity	1,457	1,549	1,141	467.4	393.23
Total Liabilities & Equity	2,071	2,112	1,727	877.91	688.72
Total Debt	26.99	25.8	29.79	6.9	3.18
Net Cash (Debt)	1,415	1,620	1,186	413.99	205.74
Net Cash Growth	-12.67%	36.55%	186.56%	101.22%	476.99%
Net Cash Per Share	9.31	11.50	9.56	3.94	2.22
Filing Date Shares Outstanding	154.81	150.98	134.14	113.64	98.83
Total Common Shares Outstanding	154.81	150.98	134.14	113.64	98.83
Working Capital	1,350	1,530	1,030	386.75	215.2
Book Value Per Share	9.41	10.25	8.50	4.11	3.97
Tangible Book Value	994.31	1,206	763.85	56.09	-52.64
Tangible Book Value Per Share	6.42	7.99	5.69	0.49	-0.53
Machinery	-	8.14	7.38	7.44	7.44
Leasehold Improvements	-	0.7	0.45	1.54	1.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.